HGF and acute myeloid leukemia: Of note, increased autonomous and/or HGF- and cytokine-induced in vitro proliferation of patient-derived leukemic cells correlated with negative clinical outcomes, including lower complete remission rates, higher risk for relapse, and shorter AML patient survival (107–109).